Tag: PubMed

J Clin Invest. | April 2024
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemias

J Cell Mol Med. | April 2022
JAK-STAT core cancer pathway: An integrative cancer interactome analysis

Immunology and Inflammation | Dec 2021
Tetramerization of STAT5 promotes autoimmune-mediated neuroinflammation

Cancers | Jan 2020
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

Cancers (Basel) | Dec 2019
Direct Targeting Options for STAT3 and STAT5 in Cancer

Cancers | Nov 2019
STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia

Haematologica | Oct 2019
The stromal microenvironment provides an escape route from FLT3 inhibitors through the GAS6-AXL-STAT5 axis

Nature Communication | June 2019
Structural and functional consequences of the STAT5B^N642H driver mutation

Nature | Jan 2019
Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia

Leukemia | May 2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Nature Communications | Nov 2017
Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells

Oncotarget | July 2014
Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia

Immunity | April 2012
STATus Report on Tetramers

Immunity | April 2012
Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function

Front Biosci. | May 2008
The different functions of Stat5 and chromatin alteration through Stat5 proteins

Cancer Cell | Jan 2005
Stat5 tetramer formation is associated with leukemogenesis